Cherrill Farnsworth Joins Shearwater Health’s Board of Directors
NASHVILLE, TN / ACCESSWIRE / November 20, 2020 / Shearwater Health, a leading provider of global healthcare solutions, announced the...
Month: November 2020
Planet 13 Opens Medizin Dispensary
LAS VEGAS, NV / ACCESSWIRE / November 20, 2020 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
Sarepta Therapeutics Named One of The Boston Globe’s Top Places to Work 2020
-- Sarepta is honored to be recognized for offering a range of benefits and work-life resources to employees and supporting...
Jushi Holdings Inc. Announces Participation at Upcoming Conferences in December 2020
BOCA RATON, Fla., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated...
Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results
NEEDHAM, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform...
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better...
Aditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™
Voorhies has Extensive Business and Industry Experience in Diagnostics & Monitoring Mountain View, CA, Nov. 20, 2020 (GLOBE NEWSWIRE)...
Jushi Holdings Inc. Increases Equity Ownership Interest in Dalitso LLC, the Company’s Majority-Owned, Virginia-Based Pharmaceutical Processor Permit Holder
Jushi Holdings Inc. Increased Equity Ownership Interest in Dalitso LLC to 79% BOCA RATON, Fla., Nov. 20, 2020 (GLOBE NEWSWIRE)...
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
MALVERN, Pa., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing...
Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting
BDTX-1535 nominated as development candidate with IND-enabling studies underway Pre-clinical data support novel and differentiated approach in GBM CAMBRIDGE, Mass....
Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference
NASHVILLE, Tenn., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that Mark Baum, Harrow’s Chief...
Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming 3CL Protease Inhibition Mechanism of Action
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused...
New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™ Test
High sensitivity and high negative predictive value (NPV) observed for ruling out the risk of preeclampsia SAN DIEGO, Nov. 20,...
Cytokinetics Names Nancy Wysenski to Board of Directors
Appointment Strengthens Commercial, Market Access and Specialty Sales Expertise as Company Advances Pipeline Toward Potential Commercialization SOUTH SAN FRANCISCO, Calif.,...
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Company announcement – No. 55 / 2020 Copenhagen, November 20, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20...
Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day
- SPEARHEAD-1 enrolment on track; planning to launch ADP-A2M4 in 2022 in the US for people with synovial sarcoma -...
BioCryst to Present at Upcoming Virtual Investment Conferences
RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will...
Matinas BioPharma Awarded up to $3.75 Million from the Cystic Fibrosis Foundation to Support Development of Oral Amikacin (MAT2501) for the Treatment of NTM Infections in Cystic Fibrosis Patients
BEDMINSTER, N.J., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused...